Summary of October 2026
October was similar to the other months of this year but like July and August, views are down on the previous two months due to 3 weeks of holiday. Still a reasonable blog performance – I can’t complain. Still managed to cover 3 new US FDA approvals!
I had many shares on many posts in October – know this, every share helps someone understand or even work towards a diagnosis, discovery of the best doctors and treatments, questions to ask about this, that and the other. The top posts this month really shows the breadth of subjects applicable to Neuroendocrine Cancer that needs to be considered. Click on the each of the 10 posts to read. Then check the goldmine that awaits you below that.
I wish I could do more but there’s just little old me! It’s amazing to think I produce more than many of the ‘big’ international/national orgs put together. Clearly I have Chris who helps with travel and hiking/cycling photos of course (for those following my exploits on Facebook Page Ronny Allan). Fortunately I have a great 2IC and admin team in my private group, so that runs as normal but also takes up a huge amount of my time.
What you can expect below;
- I’ll list the top 10 performing blog posts in October 2026. I can assure you there is some great information in there, and you may have missed some of my latest blogs which made it to the top 10. Click the blue heading or the picture on each. Every share spreads awareness and you could potentially save someone’s life. Includes some bonus posts when applicable.
- I’ll then provide the top performing post from each of my Facebook pages in the month of October (very often this is different from the top posts by views). For those not aware of my 3 Facebook public pages;
- I normally post my new blog posts on my Facebook page Neuroendocrine Cancer
- Ditto on World Neuroendocrine Cancer Day. However, I mainly do awareness posts as some people prefer those as they can share them in their own systems and audiences. I don’t mind that as long as source continues to be referenced.
- Holiday photos, personal stuff, and often some areas of amusement are normally published on my Facebook page Ronny Allan
- Finally, I will list the top performing posts so far in 2026
I’m thankful to the loyal supporters on my blog site and the other social media sites day and night (and I do note some doing both!). I really am very grateful and probably would have given up long ago, were it not for your support. If you like my work, see my ‘Buy me a coffee‘ link below.
The top 10 performing posts in October 2026
1. The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes). Click here or on the graphic to read.
2. The Cancer Legacy of Steve Jobs? Click here or on the graphic below
3. Let’s be clear – it’s a cancer – Click here or on the graphic to read.
4. Hey Cancer, I’m still here – Click here or on the graphic to read
5. 6 things you should never say to someone diagnosed with a Neuroendocrine Tumour (NET) Click here or on the graphic below.
6. Steve Jobs – the most famous Neuroendocrine Cancer Ambassador we NEVER had. Click here or on the graphic below.
7. Amneal Lanreotide Approved by US FDA. Click here or on the graphic below.
8. Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and Octreotide. Click here or on the graphic below.
9. Ronny Allan’s Newsletter covering September 2026. Click here or on the graphic below.
10. Nick Robinson – Neuroendocrine Cancer – the devil is in the detail. Click here or on the graphic below.
Bonus – links to others in the series
Spotlight on Vitamin B12. Click here or on the graphic below.
Facebook Performance October 2026 – Top performing post on each page
Facebook Page Neuroendocrine Cancer (blog mainly). Some big numbers on this page in August but this one was top by a country mile. Click here to see the Facebook post or click on the graphic below to go direct to the blog post to which it refers. This is not always about number of views, it’s about the reaction on Facebook. It helps me learn how to post.
Page Ronny Allan (personal NET stuff plus travel). Click here or on the graphic below. A nice memory from an epic visit to the Royal Observatory in Greenwich London
Facebook Page World Neuroendocrine Cancer Day (blog focussed on awareness). It was also mentioned above. Someone obviously shared that in a high volume area – many thanks to that person/those persons. Click here to see the Facebook post (and join in) or on the graphic below to go direct to the blog post to which it refers.
Top Posts this year so far Headlines – great to see two posts from my 2026 projects on vitamins and minerals and my anatomy spotlight series
Ronny is on X (formerly twitter) – click
Ronny is on Bluesky – click
Ronny is on Instagram – click
Ronny is on Threads – click
Ronny is on Pinterest – click
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional. Some content may be generated by AI which can sometimes be misinterpreted. Please check any references attached.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
General Clinical Trials Disclaimer
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided in the clinical trials document. It’s very important to check the trial inclusion and exclusion criteria before making any contact. If you need questions, the articles here is very useful Questions to Ask About Clinical Trials | Cancer.Net
The inclusion of any trial within this blog should not be taken as a recommendation by Ronny Allan. Click here to visit Ronny’s clinical trials section
If you got this far …….. Feel free to buy me a coffee to help with my website overheads – or just add a comment is also fine – it will keep me going! Click here or on the graphic below.
If you have PayPal – this link might be more friendly – Click here
Special feature – My Patient Group
The group was an afterthought. In terms of the largest patient groups across the world, mine is the newest but has grown into the biggest, perhaps the international flavour helps. In terms of membership sources, US, UK, Canada, Australia, South Africa, New Zealand, Ireland, India, Germany and Netherlands dominate making almost 90% of the group membership. I estimate over 12,000 membership by end of 2026! Not as rare as you think!
Click here and answer all questions to join my private Facebook group
Thanks for reading and sharing the newsletter. If you think someone might benefit from reading this newsletter, feel free to share.
Ronny
- A spotlight on NENs
- A spotlight on NENs – Syndromes
- A Spotlight on NENs – Testing Series
- A spotlight on NENs – Types
- Awareness
- Clinical Trials and Research
- Diet and Nutrition
- Fundraising
- General
- Humour
- Inspiration
- Latest ENETS Guidelines
- Living with Neuroendocrine Cancer
- Newsletters
- Patient Advocacy
- Ronny Allan's "The Trouble with the NET Series"
- Sometimes you gotta climb that hill!
- Spotlight on NENs – Types Series
- Survivorship
- The NET Effect Series
- Travel with Ronny
- Treatment
Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and OctreotideJanuary 15, 2025Treatment
The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes)March 11, 2024Patient Advocacy![Clinical Trial: [212Pb] Bamzireotide Navoxetan (VMT-α-NET) Alpha-emitter PRRT - Heading for Phase 3](https://i0.wp.com/ronnyallan.net/wp-content/uploads/2021/05/VMT-alpha-theranostics-3.jpg?w=640&ssl=1)
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.
